ArticleJournal of translational medicine2024
An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma.
Alberto Reale et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it